Menu Close

Articles on mRNA vaccine

Displaying all articles

Establishing public trust is now central to any decisions regarding the inoculation of our child population. (Shutterstock)

Should children get the COVID-19 vaccine?

Historically, we immunized children against diseases like polio that were a clear danger to them, but COVID-19 is usually mild in children. However, herd immunity is unlikely without vaccinating kids.
Health-care workers wait in line at a COVID-19 vaccine clinic in Toronto on Jan. 7, 2021. THE CANADIAN PRESS/Nathan Denette

COVID-19 vaccine rollout: Why a mask and social distancing are still needed, even if you get the shot

Rollout of COVID-19 vaccines has begun. But getting the jab doesn't mean abandoning masks, distancing and handwashing. Here's why the current preventive measures must continue post-vaccine.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
A volunteer gets an injection of Moderna’s possible COVID-19 vaccine on July 27, 2020. Moderna announced Nov. 16 that its vaccine is proving highly effective in a major trial. (AP Photo/Hans Pennink)

COVID-19 vaccines: How Pfizer’s and Moderna’s 95% effective mRNA shots work

Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
People wearing masks walk in front of Pfizer’s headquarters in New York City. Pfizer and BioNtech are on track with a vaccine that is 90 per cent effective, say preliminary results, but they are not the only ones in the race. AP Photo/Bebeto Matthews

COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets

Canada has set aside a total of 414 million doses of different types of vaccine. Some exploit known mechanisms, others are based on previously untested approaches.
Moderna just released the results of a phase 1 trial for a COVID-19 vaccine. JOSEPH PREZIOSO/AFP via Getty Images

What the phase 1 trials of the first COVID-19 vaccine really mean

Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.

Top contributors

More